Gender-related differences in drug-induced prolongation of cardiac repolarization in prepubertal guinea pigs

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 1, 2009, Pages 28-37

  Hreiche, Raymond ^a   Morissette, Pierre ^a   Zakrzewski Jakubiak, Hubert ^a   Turgeon, Jacques ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiac repolarization; Drug induced long QT syndrome; Gender; Membrane transporters; Potassium channel blockers

Indexed keywords

DOFETILIDE; DOMPERIDONE; INDAPAMIDE; VERAPAMIL;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; GUINEA PIG; HEART REPOLARIZATION; MALE; NONHUMAN; POTASSIUM CURRENT; PREPUBERTY; PRIORITY JOURNAL; QT PROLONGATION;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DELAYED RECTIFIER POTASSIUM CHANNELS; DOMPERIDONE; FEMALE; GUINEA PIGS; HEART CONDUCTION SYSTEM; INDAPAMIDE; LONG QT SYNDROME; MALE; PHENETHYLAMINES; POTASSIUM CHANNEL BLOCKERS; SEX FACTORS; SEXUAL DEVELOPMENT; SULFONAMIDES; TIME FACTORS; VERAPAMIL;

EID: 61449189813     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248408331018     Document Type: Article

References (35)

1. Morissette P., Hreiche R., Turgeon J. Drug-induced long QT syndrome and torsade de pointes. Can J Cardiol. 2005; 21: 857-864.
2. Selzer A., Wray HW Quinidine syncope. Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation. 1964; 30: 17-26.
3. Roden DM Drug-induced prolongation of the QT interval. N Engl J Med. 2004; 350: 1013-1022.
4. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993; 270: 2590-2597.
5. Bazett A. An analysis of the time relationship of electrocardiograms. Heart. 1920; 7: 353-370.
6. Rautaharju PM, Zhou SH, Wong S., et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 1992; 8: 690-695.
7. Drici MD, Burklow TR, Haridasse V., Glazer RI, Woosley RL Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation. 1996; 94: 1471-1474.
8. Rodriguez I., Kilborn MJ, Liu XK, Pezzullo JC, Woosley RL Drug-induced QT prolongation in women during the menstrual cycle. JAMA. 2001; 285: 1322-1326.
9. Hunt CM, Westerkam WR, Stave GM Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol. 1992; 44: 275-283.
10. Morris ME, Lee HJ, Predko LM Gender differences in the membrane transport of endogenous and exogenous compounds. Pharmacol Rev. 2003; 55: 229-240.
11. Kleinman LI, Loewenstein MS, Goldstein L. Sex difference in the transport of p-aminohippurate by the rat kidney. Endocrinology. 1966; 78: 403-406.
12. Orzes N., Bellentani S., Aldini R., et al. Sex differences in the hepatic uptake of sulphobromophthalein in the rat. Clin Sci (Lond). 1985; 69: 587-593.
13. Anton FM, Garcia Puig J., Ramos T., Gonzalez P., Ordas J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986; 35: 343-348.
14. Schuetz EG, Furuya KN, Schuetz JD Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther. 1995; 275: 1011-1018.
15. Couture L., Nash JA, Turgeon J. The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart. Pharmacol Rev. 2006; 58: 244-258.
16. Morissette P., Hreiche R., Turgeon J. Modulatory role of verapamil treatment on the cardiac electrophysiological effects of cisapride. Can J Physiol Pharmacol. 2007; 84: 1285-1290.
17. Drolet B., Khalifa M., Daleau P., Hamelin BA, Turgeon J. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation. 1998; 97: 204-210.
18. Zhang S., Zhou Z., Gong Q., Makielski JC, January CT Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Circ Res. 1999; 84: 989-998.
19. Rasmussen HS, Allen MJ, Blackburn KJ, Butrous GS, Dalrymple HW Dofetilide, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol. 1992; 20 (suppl 2). S96 - S105.
20. Drolet B., Rousseau G., Daleau P., Cardinal R., Turgeon J. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation. 2000; 102: 1883-1885.
21. El Ela AA, Hartter S., Schmitt U., Hiemke C., Spahn-Langguth H., Langguth P. Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds-implications for pharmacokinetics of selected substrates. J Pharm Pharmacol. 2004 ; 56: 967-975.
22. Schinkel AH, Wagenaar E., Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1996; 97: 2517-2524.
23. Yamreudeewong W., DeBisschop M., Martin LG, Lower DL Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Saf. 2003; 26: 421-438.
24. Turgeon J., Daleau P., Bennett PB, Wiggins SS, Selby L., Roden DM Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytes. Circ Res. 1994; 75: 879-886.
25. James AF, Arberry LA, Hancox JC Gender-related differences in ventricular myocyte repolarization in the guinea pig. Basic Res Cardiol. 2004; 99: 183-192.
26. Brouillette J., Lupien MA, St- Michel C., Fiset C. Characterization of ventricular repolarization in male and female guinea pigs. J Mol Cell Cardiol. 2007; 42: 357-366.
27. Fiset C., Drolet B., Hamelin BA, Turgeon J. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol. J Pharmacol Exp Ther. 1997; 283: 148-156.
28. Varro A., Lathrop DA, Hester SB, Nanasi PP, Papp JG Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res Cardiol. 1993; 88: 93-102.
29. Nerbonne JM Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J Physiol. 2000; 525 (pt 2). 285-298.
30. Grube M., Kock K., Oswald S., et al. Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther. 2006; 80: 607-620.
31. Hagenbuch B., Meier PJ The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta. 2003; 1609: 1-18.
32. Leu BL, Huang JD Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother Pharmacol. 1995; 35: 432-436.
33. Meerum Terwogt JM, Beijnen JH, ten Bokkel Huinink WW, Rosing H., Schellens JH Co-administration of cyclosporin enables oral therapy with paclitaxel. Lancet. 1998; 352: 285.
34. Grube M., Meyer zu Schwabedissen HE, Prager D., et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation. 2006; 113: 1114-1122.
35. Letsas KP, Alexanian IP, Pappas LK, et al. QT interval prolongation and torsade de pointes associated with indapamide. Int J Cardiol. 2006; 112: 373-374.